Phlorotannins have shown promise in animal models for their multitarget actions, as they not only reduce oxidative damage but also inhibit the aggregation of neurotoxic proteins like Ab in AD and alpha-synuclein in PD. The gene discussed is SNCA; the disease is Parkinson disease.